AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From AP Worldstream)
Byline: LAURAN NEERGAARD
Alzheimer's patients may soon get the first skin patch to treat the creeping brain degeneration, a novel way to deliver an older drug so that it's easier to take and might even work a little better.
The patch, which infuses the drug Exelon through patients' skin, headlines a trio of innovative potential treatments unveiled Wednesday at an international Alzheimer's meeting. Also under study are a prostate cancer drug that may also help dementia and an immune therapy to ward off the sticky gunk that is Alzheimer's brain-clogging hallmark.
The Exelon patch is furthest in the pipeline, with maker Novartis Pharmaceuticals Corp. poised to seek U.S. sales approval by year's end.
"It…